Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Oncology and Cancer Research
Published in: Clinical Oncology and Cancer Research 1/2010

01-02-2010

Neoadjuvant combination chemotherapy with pegylated liposomal doxorubicin and vinorelbine for locally advanced breast cancer

Authors: Zhen-zhou Shen, Zhi-min Shao, Bing-he Xu, Ling Wang, Yong-sheng Wang, Jian Liu, Ping-qing He, Feng-xi Su, Ze-fei Jiang, Bin Zhang, Lian-fang Li

Published in: Clinical Oncology and Cancer Research | Issue 1/2010

Login to get access
Metadata
Title
Neoadjuvant combination chemotherapy with pegylated liposomal doxorubicin and vinorelbine for locally advanced breast cancer
Authors
Zhen-zhou Shen
Zhi-min Shao
Bing-he Xu
Ling Wang
Yong-sheng Wang
Jian Liu
Ping-qing He
Feng-xi Su
Ze-fei Jiang
Bin Zhang
Lian-fang Li
Publication date
01-02-2010
Publisher
Tianjin Medical University Cancer Institute and Hospital
Published in
Clinical Oncology and Cancer Research / Issue 1/2010
Print ISSN: 1674-5361
Electronic ISSN: 1868-324X
DOI
https://doi.org/10.1007/s11805-010-0007-0

Other articles of this Issue 1/2010

Clinical Oncology and Cancer Research 1/2010 Go to the issue

OriginalPaper

Selective internal iliac artery oxaliplatin infusion: Another facultative treatment to unremitting hematuria in stage T4 bladder carcinoma

OriginalPaper

Choroid plexus papilloma of the fourth ventricle developing postoperative intracranial and rectal hemorrhage three times: A case report

OriginalPaper

Clinical observation of concurrent radio-chemotherapy combined with adjuvant chemotherapy in treating locoregionally advanced nasopharyngeal carcinoma

OriginalPaper

Alveolar rhabdomyosarcoma of the laryngohypopharynx: A case report

OriginalPaper

Genetic polymorphism in the second exon of HLA-DRB1 in cervical cancer

OriginalPaper

Inhibition of the growth of Raji cells by precursor microRNA-5a
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits